Evidence map›Paper›PMID 41362877›Full record

ReviewLancet regional health. Americas2025

Type 5 diabetes: a 70-year perspective and its implications for the Americas.

Pradnyashree Wadivkar, Debbie S Thompson, Meredith Shamamian, Meredith Hawkins, Michael S Boyne

Abstract readReview
In one paragraph

Review in Lancet regional health. Americas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pradnyashree WadivkarDepartment of Endocrinology, Global Diabetes Institute, Albert Einstein College of Medicine, New York, NY, USA.
Debbie S ThompsonCaribbean Institute for Health Research, The University of the West Indies, Mona Campus, Kingston, Jamaica.
Meredith ShamamianDepartment of Endocrinology, Global Diabetes Institute, Albert Einstein College of Medicine, New York, NY, USA.
Meredith HawkinsDepartment of Endocrinology, Global Diabetes Institute, Albert Einstein College of Medicine, New York, NY, USA.
Michael S BoyneDepartment of Medicine, The University of the West Indies, Mona Campus, Kingston, Jamaica.

Funding

Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Shuibing Chen · 2015 to 2026
$27.7M
Role of Hepatic Fat Metabolism in Glucose EffectivenessR01DK069861 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HAWKINS, MEREDITH A, ROUTH, VANESSA H · 2006 to 2025
$7.6M
NIDDK NIH HHS P30 DK020541NIDDK NIH HHS R01 DK069861
6 · The paper itself

Abstract

Type 5 Diabetes (T5DM) was first identified by Hugh-Jones in Jamaica in 1955 as J-type diabetes. Since then, multiple reports from various countries have supported the idea that T5DM differs from other known forms of diabetes. Common features that distinguish T5DM include a body mass index of <18.5 kg/m

Indexed as

Body mass indexDiabetes mellitusInsulin secretionKetosisMalnutritionPancreaticProtein-energy malnutritionThinness

Identifiers

PMID41362877
PMCPMC12681795

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.